| Diabeloop S.A.. (12/2/19). "Press Release: Diabeloop Completes Record-breaking European Fundraising Effort With Its Autonomous Diabetes Management Solutions". Grenoble. |
2019-12-02 |
| Ligand Pharmaceuticals Inc.. (12/2/19). "Press Release: Ligand Enters into Worldwide OmniAb Platform License Agreement with Sanofi". San Diego, CA. |
2019-12-02 |
| Owkin. (12/2/19). "Press Release: Owkin Teams up with NVIDIA and King's College London to Deliver AI to Hospitals While Protecting Patient Data With Federated Learning". Paris & New York. |
2019-12-02 |
| BRAIN AG. (12/2/19). "Press Release: New Chairman of the Management Board – Adriaan Moelker Takes Over from Dr Jürgen Eck". Zwingenberg. |
2019-12-02 |
| Max-Delbrück-Centrum für Molekulare Medizin (MDC). (12/2/19). "Press Release: Deep Learning Identifies Molecular Patterns of Cancer". Berlin. |
2019-12-02 |
| Puma Biotechnology, Inc.. (12/2/19). "Press Release: Puma Biotechnology Amends License Agreement with Pierre Fabre to Include Additional Countries". Berlin. |
2019-12-02 |
| Sensorion S.A.. (12/2/19). "Press Release: Sensorion Announces Results From SENS-111 Phase 2b Trial in Acute Unilateral Vestibulopathy". Montpellier. |
2019-12-02 |
| Indivumed GmbH. (12/2/19). "Press Release: Indivumed Announces Strategic Partnership with Biognosys". Hamburg & Schlieren. |
2019-12-02 |
| European Invesmtent Bank (EIB). (11/29/19). "Press Release: A European Fund to Support the Circular Bioeconomy". |
2019-11-29 |
| Avantium N.V.. (11/28/19). "Press Release: Avantium Secures Financing Milestone with €25 million EU Funding for FDCA Flagship Plant". Amsterdam. |
2019-11-28 |
| ViGeneron GmbH. (11/28/19). "Press Release: ViGeneron Announces Closing of Series A Financing to Drive Development of Next Generation Gene Therapy Pipeline". Munich. |
2019-11-28 |
| MedinCell S.A.. (11/28/19). "Press Release: MedinCell Receives $19 Million Grant for Its mdc-WWM Program". Montpellier. |
2019-11-28 |
| Qiagen N.V.. (11/27/19). "Press Release: Qiagen and DiaSorin Receive FDA Approval for the Liaison QuantiFERON-TB Gold Plus Test on Liaison Platforms and Begin Commercial Launch". Germantown, MD, Hilden & Saluggia. |
2019-11-27 |
| Merck KGaA. (11/26/19). "Press Release: Japan and Singapore Grant CRISPR Patents to Merck". Darmstadt. |
2019-11-26 |
| MaxiVax S.A.. (11/26/19). "Press Release: MaxiVax Awarded €2,785,000 European Commission Grant and Announces Successful Closing of Its Series B 2 Round for an Amount of CHF 5 Million". Geneva. |
2019-11-26 |
| GeNeuro S.A.. (11/25/19). "Press Release: GeNeuro and the Karolinska Institutet/Academic Specialist Center of Stockholm Agree to Launch a New Clinical Study of Temelimab in Multiple Sclerosis". Geneva. |
2019-11-25 |
| Roche. (11/25/19). "Press Release: FDA Grants Priority Review to Roche’s Risdiplam for Spinal Muscular Atrophy". Basel. |
2019-11-25 |
| BCNP Consultants GmbH. (11/25/19). "Press Release: World Café »Digitization of the Coating Industry« at the 4th European Chemistry Partnering on February 27, 2020". Frankfurt a. M.. |
2019-11-25 |
| Novartis AG. (11/24/19). "Press Release: Novartis to Acquire The Medicines Company for USD 9.7 bn". Basel. |
2019-11-24 |
| Roche. (11/22/19). "Press Release: Roche Presents Pivotal Data Demonstrating Tecentriq in Combination with Avastin Improves Overall Survival in People with the Most Common Form of Liver Cancer". Basel. |
2019-11-22 |
| Tissium. (11/20/19). "Press Release: Tissium Closes €39M Series B Funding Round". Paris. |
2019-11-20 |
| Coulter Partners. (11/20/19). "Press Release: Coulter Partners Opens Brussels Office and Makes Six Strategic Appointments". |
2019-11-20 |
| MorphoSys AG. (11/20/19). "Press Release: Markus Enzelberger, Chief Scientific Officer of MorphoSys, Announces His Departure". Planegg. |
2019-11-20 |
| Sophia Genetics S.A.. (11/20/19). "Press Release: Sophia Genetics Welcomes Milton Silva-Craig to Its Board of Directors". Boston, MA & Lausanne. |
2019-11-20 |
| Qiagen N.V.. (11/20/19). "Press Release: Qiagen and LabCorp Deepen Relationship with Widespread Use of Bioinformatics Solutions". Hilden & Germantown, MD. |
2019-11-20 |
| CRISPR Therapeutics AG. (11/20/19). "Press Release: CRISPR Therapeutics Announces Pricing of Public Offering of Common Shares". Zug & Cambridge, MA. |
2019-11-20 |
| Merck KGaA. (11/20/19). "Press Release: Merck Announces Orphan Drug Designation for Investigational Therapy Tepotinib in Patients with NSCLC Harboring MET Gene Alterations 8Not intended for UK-based media]". Darmstadt. |
2019-11-20 |
| CRISPR Therapeutics AG. (11/19/19). "Press Release: CRISPR Therapeutics and Vertex Announce Positive Safety and Efficacy Data From First Two Patients Treated With Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001 for Severe Hemoglobinopathies". Zug |
2019-11-19 |
| CRISPR Therapeutics AG. (11/19/19). "Press Release: CRISPR Therapeutics Announces Proposed Public Offering of Common Shares". Zug & Cambridge, MA. |
2019-11-19 |
| Zelluna Immunotherapy AS. (11/19/19). "Press Release: Zelluna Immunotherapy and Glycostem Therapeutics Announce Partnership to Develop Allogeneic TCR-NK Therapies". Oslo & Oss. |
2019-11-19 |
| Qiagen N.V.. (11/15/19). "Press Release: Qiagen Receives Several Conditional, Non-binding Indications of Interest, Enters into Discussions to Explore Potential Strategic Alternatives". Venlo. |
2019-11-15 |
| Innate Pharma S.A.. (11/13/19). "Press Release: Innate Pharma Third Quarter 2019 Report". |
2019-11-13 |
| Lonza Group Ltd.. (11/12/19). "Press Release: Board Announcement". Basel. |
2019-11-12 |
| ProBioGen AG. (11/12/19). "Press Release: DirectedLuck, a Transposase for Efficient Gene Delivery and High-Titer Cell Line Development". Berlin. |
2019-11-12 |
| Genedata AG. (11/12/19). "Press Release: Immatics Implements Genedata Biologics into Proprietary T-Cell Receptor Discovery and Engineering XCEPTOR Platform". Basel. |
2019-11-12 |
| Vaximm AG. (11/12/19). "Press Release: NEC and Vaximm Announce Collaboration to Advance Personalized Neoantigen Cancer Vaccines". Tokyo, Basel & Mannheim. |
2019-11-12 |
| Merck KGaA. (11/12/19). "Press Release: Merck Licenses CRISPR Gene-Editing Technology to Evotec". Darmstadt. |
2019-11-12 |
| Kiadis Pharma N.V.. (11/12/19). "Press Release: Kiadis Pharma Changes Strategy to Focus Solely on Development of Natural Killer (NK) Cell Therapeutics and Terminates Development of ATIR101". Amsterdam. |
2019-11-12 |
| 4SC AG. (11/12/19). "Press Release: 4SC AG Secures circa EUR 22.4 Million from a Capital Increase [Not for release in US, Australia, Canada, et al.]". Planegg-Martinsried. |
2019-11-12 |
| [iito] Business Intelligence. (11/11/19). "Press Release: [iito] Launches Transatlantic Life Sciences Business Portal at BIO-Europe". Bremen & Hamburg. |
2019-11-11 |
| Expedeon AG. (11/11/19). "Press Release: Expedeon AG Signs EUR 120 Million Deal with Abcam for the Sale of Its immunology and Proteomics Business". Heidelberg & Cambridge. |
2019-11-11 |
| Argenx SE. (11/8/19). "Press Release: Argenx Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs". Breda & Ghent. |
2019-11-08 |
| eGenesis Inc.. (11/7/19). "Press Release: eGenesis Announces $100 Million Series B Financing". Cambridge, MA. |
2019-11-07 |
| Argenx SE. (11/7/19). "Press Release: Argenx Raises $484 Million in Gross Proceeds in a Global Offering". Breda & Ghent. |
2019-11-07 |
| Centogene B.V.. (11/7/19). "Press Release: Centogene Announces Pricing of Initial Public Offering". Cambridge, MA & Rostock. |
2019-11-07 |
| Owlstone Medical Ltd.. (11/7/19). "Press Release: Owlstone Medical Enters Partnership with Thermo Fisher Scientific to Advance Early Disease Detection Using Non-invasive Breath Biopsy". Cambridge. |
2019-11-07 |
| Urania Therapeutics S.A.S.. (11/6/19). "Press Release: Urania Therapeutics Closes a €3.5M Initial Seed Round". Strasbourg. |
2019-11-06 |
| Argenx SE. (11/6/19). "Press Release: Argenx Announces Launch of Proposed Global Offering". Breda & Ghent. |
2019-11-06 |
| Evotec SE. (11/6/19). "Press Release: Evotec and Vifor Pharma Form Joint Venture for Early Development in Nephrology". Hamburg & St. Gallen. |
2019-11-06 |
| Poxel S.A.. (11/5/19). "Press Release: Poxel Obtains Additional Funding to Advance Pipeline Programs. Financing of up to EUR 30 Million through a Bond Loan with IPF Partners". Lyon. |
2019-11-05 |
| SciRhom GmbH. (11/5/19). "Press Release: SciRhom Initiates First-In-Class Antibody Development Program to Treat Major Autoimmune Diseases". Munich. |
2019-11-05 |
| ADC Therapeutics S.A.. (11/5/19). "Press Release: ADC Therapeutics Appoints Jennifer Herron as Chief Commercial Officer". Lausanne. |
2019-11-05 |
| Xlife Sciences AG. (11/4/19). "Press Release: Xlife Siences AG. New Project in the Portfolio". Zurich. |
2019-11-04 |
| Santhera Pharmaceuticals AG. (11/4/19). "Press Release: Santhera Appoints New Chief Executive Officer". Pratteln. |
2019-11-04 |
| Roivant Sciences GmbH. (10/31/19). "Press Release: Sumitomo Dainippon Pharma and Roivant Sciences Sign Definitive Agreement for Strategic Alliance". Tokyo, Osaka, London & Basel. |
2019-10-31 |
| AstraZeneca plc. (10/30/19). "Press Release: AstraZeneca Divests Rights to Seroquel and Seroquel XR in Europe and Russia". |
2019-10-30 |
| genOway S.A.. (10/30/19). "Press Release: The Institut Pasteur and Cellectis Extend Exclusive License Rights by Granting genOway the Authority to Take Action against Infringement". Lyon & Paris. |
2019-10-30 |
| Cellectis S.A.. (10/29/19). "Press Release: First Patient Dosed with Off-the-Shelf UCARTCS1 Product Candidate for Relapsed/Refractory Multiple Myeloma". New York, NY. |
2019-10-29 |
| CEM Corporation. (10/29/19). "Press Release: CEM Corporation Acquires Key Assets of Intavis Bioanalytical Instruments". Matthews, NC. |
2019-10-29 |
| Themis Bioscience GmbH. (10/29/19). "Press Release: Themis Bioscience and CEPI Announce Initiation of Phase 1 Clinical Trial with Lassa Fever Vaccine". Vienna & Oslo. |
2019-10-29 |
| Boehringer Ingelheim. (10/29/19). "Press Release: Boehringer Ingelheim Advances First Pan-KRAS Inhibitor BI 1701963 into Clinical Testing". Ingelheim. |
2019-10-29 |
| CRISPR Therapeutics AG. (10/28/19). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2019 Financial Results". Zug & Cambridge, MA. |
2019-10-28 |
| Cato Research, LLC. (10/28/19). "Press Release: Cato Research Announces Merger with SMS-Oncology". Durham, NC. |
2019-10-28 |
| MorphoSys AG. (10/28/19). "Press Release: MOR106 Clinical Development in Atopic Dermatitis Stopped for Futility". Planegg & Mechelen. |
2019-10-28 |
| Curetis N.V.. (10/28/19). "Press Release: Curetis Group Company Ares Genetics Launches AI-powered Molecular Antibiotic Susceptibility Test". Vienna & Holzgerlingen. |
2019-10-28 |
| Uniqure N.V.. (10/28/19). "Press Release: Uniqure Announces Third Quarter 2019 Results and Highlights Recent Company Progress". Lexington, MA & Amsterdam. |
2019-10-28 |
| Centogene B.V.. (10/28/19). "Press Release: Centogene Announces Proposed Initial Public Offering of Common Shares". Cambridge, MA & Rostock. |
2019-10-28 |
| OpGen, Inc.. (10/28/19). "Press Release: OpGen Announces Closing of $9.4 Million Underwritten Public Offering". Gaithersburg, MD. |
2019-10-28 |
| Galapagos N.V.. (10/25/19). "Press Release: Galapagos Receives Transparency Notification from Wellington Management Group LLP". Mechelen. |
2019-10-25 |
| Galapagos N.V.. (10/24/19). "Press Release: Solid Third Quarter 2019 Performance with Strong Balance Sheet for Continued R&D Growth". Mechelen. |
2019-10-24 |
| OpGen, Inc.. (10/23/19). "Press Release: OpGen Announces Pricing of $9.4 Million Underwritten Offering". Gaithersburg, MD. |
2019-10-23 |
| Evotec SE. (10/23/19). "Press Release: Evotec, Integra Holdings and Yissum Establish LAB555 to Fast Track Early-stage Drug Development". Hamburg. |
2019-10-23 |
| PhagoMed Biopharma GmbH. (10/22/19). "Press Release: Phage Lysin Stabilzes Vaginal Microbiome. PhageMed Accelerates R6D Program against Bacterial Vaginosis". Vienna. |
2019-10-22 |
| MCG Motion Capture GmbH. (10/22/19). "Press Release: Motion Capture Group Retains Biotech Alliances International to Raise Series A $15 Million Financing Round". Heidelberg & San Francisco, CA. |
2019-10-22 |
| Bluebird Bio, Inc.. (10/22/19). "Press Release: European Medicines Agency Approves Refined Commercial Manufacturing Specifications for Zynteglo". Cambridge, MA. |
2019-10-22 |
| Arnold & Porter LLP. (10/22/19). "Press Release: Life Sciences Lawyer and Former EMA Legal Adviser Alexander Roussanov Joins Arnold & Porter in Brussels". Brussels. |
2019-10-22 |
| Kiadis Pharma N.V.. (10/22/19). "Press Release: Kiadis Pharma Announces Formation of Renowned Scientific Advisory Board". Amsterdam. |
2019-10-22 |
| CRISPR Therapeutics AG. (10/21/19). "Press Release: CRISPR Therapeutics and Bayer Announce an Update on Casebia Therapeutics". Leverkusen, Zug & Cambridge, MA. |
2019-10-21 |
| Innate Pharma S.A.. (10/21/19). "Press Release: Innate Pharma Announces Closing of Global Offering". Marseille. |
2019-10-21 |
| Danaher Corporation. (10/21/19). "Press Release: Danaher Reaches Agreement to Sell Certain Businesses to Sartorius AG as Part of the GE Biopharma Acquisition Regulatory Process". Washington, DC. |
2019-10-21 |
| Biocat. (10/21/19). "Press Release: Boehringer Ingelheim Joins the d·HEALTH Barcelona Program to Foster Innovation in Health". Barcelona. |
2019-10-21 |
| Arcutis Biotherapeutics, Inc.. (10/21/19). "Press Release: Arcutis Announces the Completion of $94.5 Million Series C Financing". Westlake Village, CA. |
2019-10-21 |
| Innate Pharma S.A.. (10/18/19). "Press Release: Innate Pharma Announces the Exercies in Full of the Option to the Underwriters of Its Global Offering and Nasdaq Global Select Market Listing to Purchase 1,87500 Additional ADSs". Marseille. |
2019-10-18 |
| Plexium, Inc.. (10/17/19). "Press Release: Plexium Launches with $28 Million in Series A Financing". San Diego, CA. |
2019-10-17 |
| BC Platforms. (10/17/19). "Press Release: BC Platforms Partners with Blueprint Genetics to Provide Center of Excellence for Data Driven Testing Services in Rare Diseases". Zürich & Boston, MA. |
2019-10-17 |
| Sofinnova Partners. (10/17/19). "Press Release: Sofinnova Partners Raises €333 Million Capital IX Early-stage Healthcare Fund". Paris. |
2019-10-17 |
| Kiadis Pharma N.V.. (10/17/19). "Press Release: Kiadis Pharma Provides Regulatory Update on ATIR101". Amsterdam. |
2019-10-17 |
| Amarna Therapeutics B.V.. (10/16/19). "Press Release: Amarna Therapeutics Raises €10 Million to Progress Lead Development Candidate into Clinical Trials and Appoints a New Supervisory Board". Leiden. |
2019-10-16 |
| Abalos Therapeutics GmbH. (10/15/19). "Press Release: Abalos Therapeutics Launches with €12M Series A Round to Develop Novel Immuno-Virotherapies Against Cancer". Essen. |
2019-10-15 |
| Numab Therapeutics AG. (10/15/19). "Press Release: Numab Appoints Daniel Vasella to Board of Directors". Wädenswil (Zurich). |
2019-10-15 |
| CRISPR Therapeutics AG. (10/15/19). "Press Release: CRISPR Therapeutics and KSQ Therapeutics Announce License Agreement to Advance Companies’ Respective Cell Therapy Programs in Oncology". Zug & Cambridge, MA. |
2019-10-15 |
| MorphoSys AG. (10/14/19). "Press Release: MorphoSys and I-Mab Biopharma Announce IND Clearance to Initiate Clinical Trials of MOR202/TJ202 for the Treatment of Multiple Myeloma in Mainland China". Planegg & Shanghai. |
2019-10-14 |
| BioNTech SE. (10/10/19). "Press Release: BioNTech Announces Pricing of Initial Public Offering". Mainz. |
2019-10-10 |
| Merck KGaA. (10/10/19). "Press Release: Merck Becomes the First to Use Acoustic Technology for Cell Therapy Manufacturing". Darmstadt. |
2019-10-10 |
| Galapagos N.V.. (10/10/19). "Press Release: Gilead and Galapagos Announce Efficacy and Safety Results of Filgotinib through 52 Weeks in FINCH 1 and FINCH 3 Studies in Rheumatoid Arthritis". Foster City, CA & Mechelen. |
2019-10-10 |
| UCB S.A.. (10/10/19). "Press Release: UCB Agrees to Acquire Ra Pharmaceuticals". Brussels & Cambridge, MA. |
2019-10-10 |
| Roivant Sciences GmbH. (10/9/19). "Press Release: Parexel and Datavant Enter Multi-Year Strategic Partnership to Enable the Connection of Real-World Data Across All Parexel Clinical Trials". Boston, MA & San Francisco, CA. |
2019-10-09 |
| Evotec SE. (10/9/19). "Press Release: Evotec and Celmatix Enter into Strategic Collaboration". Hamburg & New York, NY. |
2019-10-09 |
| iOmx Therapeutics AG. (10/9/19). "Press Release: iOmx Therapeutics Strengthens Executive Management Team and Supervisory Board". Martinsried. |
2019-10-09 |
| Vivoryon Therapeutics AG. (10/8/19). "Press Release: Vivoryon Therapeutics AG Launches Rights Offering to Fund its Phase 2b Clinical Development Program in Alzheimer’s Disease with Strong Commitments [Not for US, et al.]". Halle (Saale). |
2019-10-08 |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo-2019.png){kind=logo}
Date![Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px](/banner/iito-20190621-650-089-life-sciences-asia.jpg)
![Picture [iito] LSUS iitoLifeScience Transatlantic Life Sciences 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
